Influence of acute or chronic calcium channel antagonists on the acquisition and consolidation of memory and nicotine-induced cognitive effects in mice

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 7, 2013, Pages 651-664

  Biala, Grazyna ^a   Kruk Slomka, Marta ^a   Jozwiak, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Calcium channel antagonists; Cholinergic receptors; Memory; Mice; Modified elevated plus maze; Nicotine

Indexed keywords

AMFEBUTAMONE; AMLODIPINE; FLUNARIZINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM HOMEOSTASIS; COGNITION; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN;

ANIMALS; CALCIUM CHANNEL BLOCKERS; MALE; MAZE LEARNING; MEMORY; MICE; NICOTINE;

EID: 84879112415     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-013-0866-z     Document Type: Article

References (81)

1. Adam LP, Henderson EG (1990) Calcium channel effectors are potent non-competitive blockers of acetylcholine receptors. Pflugers Arch 416:586-593
2. Barrantes GE, Murphy CT, Westwick J, Wonnacott S (1995) Nicotine increases intracellular calcium, in rat hippocampal neurons via voltage-gated calcium channels. Neurosci Lett 196:101-104
3. Bauer EP, Schaffe GE, LeDoux JE (2002) NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory in the lateral amygdale. J Neurosci 22:5239-5249
4. Bean BP (1989) Classes of calcium channels in vertebrate cells. Annu Rev Physiol 51:367-384
5. Bencherif M, Schmitt JD (2002) Targeting neuronal nicotinic receptors: a path to new therapies. Current Drug Targets CNS Neurol Disord 1:349-357
6. Biala G (2003) Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents. Pol J Pharmacol 55:327-335
7. Biala G, Budzynska B (2006) Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists. Eur J Pharmacol 537:85-93
8. Biala G, Budzynska B (2008) Calcium-dependent mechanisms of the reinstatement of nicotine conditioned place preference by drug priming in rats. Pharmacol Biochem Behav 89:116-125
9. Biala G, Weglinska B (2004) Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801. J Pharm Pharmacol 56:1021-1028
10. Biala G, Weglinska B (2005) Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists. Pharmacol Res 51:483-488
11. Biala G, Kruk M (2008) Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze in mice. Behav Brain Res 192:198-202
12. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long term potentiation in the hippocampus. Nature 361:31-39
13. Borroni AM, Fichtenholtz H, Woodside BL, Teyler TJ (2000) Role of voltage-dependent calcium channel long-term potentiation (LTP) and NMDA LTP in spatial memory. J Neurosci 20:9272-9276
14. Buccafusco JJ (2004) Neuronal nicotinic receptor subtypes: defining therapeutic targets. Mol Intervent 4:285-295
15. Buisson B, Bertrand D (1998) Allosteric modulation of neuronal nicotinic acetylcholine receptors. J Physiol Paris 92:89-100
16. Cain CK, Blouin AM, Barad M (2002) L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice. J Neurosci 22:9113-9121
17. Dajas-Bailador F, Wonnacott S (2004) Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25:317-324
18. Damaj MI (2000) The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in mice. Eur J Pharmacol 404:103-110
19. Dani JA, De Biasi M (2001) Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70:439-446
20. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314
21. Finger S, Green L, Tarnoff ME, Mortman KD, Andersen A (1990) Nimodipine enhances new learning after hippocampal damage. Exp Neurol 109:279-285
22. Freir DB, Herron CE (2003) Inhibition of L-type voltage dependent calcium channels causes impairment of long-term potentiation in the hippocampal CA1 region in vivo. Brain Res 967:27-36
23. Friederich P, Dybek A, Urban BW (2000) Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells. Anesthesiology 93:818-824
24. Genkova-Papazova MG, Petkova BP, Lazarova-Bakarova M, Boyanova E, Staneva-Stoytcheva D (1997) Effects of flunarazine and nitrendipine on electroconvulsive shock- and clonidine-induced amnesia. Pharmacol Biochem Behav 56:583-587
25. Genkova-Papazova MG, Petkova BP, Shishkova N, Lazarova-Bakarova M (2001) Effect of the calcium channel blockers nifedipine and diltiazem on pentylenetetrazole kindling-provoked amnesia in rats. Eur Neuropsychopharmacol 11:91-96
26. Gotti C, Zoli M, Clementi F (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27:482-491
27. Hefco V, Yamada K, Hefco A, Hritcu L, Tiron A, Olariu A, Nabeshima T (2003) Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats. Eur J Pharmacol 474:227-232
28. Hliňák Z, Krejčí I (1998) Concurrent administration of subeffective doses of scopolamine and MK-801 produces a short-term amnesia for the elevated plus-maze in mice. Behav Brain Res 91:83-89
29. Hliňák Z, Krejčí I (2002) Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice. Behav Brain Res 133:395-399
30. Isaacson RL, Maier DL, Mandel AH (1989) Post training or pretest administration of nimodipine fails to affect retention of a simple learned association. Physiol Behav 46:191-193
31. Itoh J, Nabeshima T, Kameyama T (1990) Utility of an elevated plus maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 101:27-33
32. Itoh J, Nabeshima T, Kameyama T (1991) Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol 194:71-76
33. Izquierdo I, Medina JH (1997) The biochemistry of memory formation and its regulation by hormones and neuromodulators. Psychobiology 25:1-9
34. Jackson KJ, Martin BP, Changeux JP, Damaj MI (2008) Differential role of nicotinic acetylcholine receptor subunits in physical and affective withdrawal signs. J Pharmacol Exp Ther 325:302-312
35. Jozwiak K, Moaddel R, Ravichandran S, Plazinska A, Kozak J, Patel S et al (2008) Exploring enantiospecific ligand-protein interactions using cellular membrane affinity chromatography: chiral recognition as a dynamic process. J Chromatogr B Analyt Technol Biomed Life Sci 875:200-207
36. Jozwiak K, Moaddel R, Yamaguchi R, Ravichandran S, Collins JR, Wainer IW (2005) Qualitative assessment of IC50 values of inhibitors of the neuronal nicotinic acetylcholine receptor using a single chromatographic experiment and multivariate cluster analysis. J Chromatogr B Analyt Technol Biomed Life Sci 819:169-174
37. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC et al (2006) Antihypertensive medication use and incident Alzheimer disease. The Cache County Study. Arch Neurol 63:686-692
38. Kruk M, Tendera K, Biala G (2011) Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test. Pharmacol Rep 63:1372-1382
39. Kruk-Slomka M, Budzynska B, Biala G (2012) Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice. Pharmacol Rep 64:1066-1080
40. Lashgari R, Motamedi F, Asl SZ, Shahidi S, Komaki A (2006) Behavioral and electrophysiological studies of chronic oral administration of L-type calcium channel blocker verapamil on learning and memory in rats. Behav Brain Res 171:324-328
41. Leonard S, Bertrand D (2001) Neuronal nicotinic receptors: from structure to function. Nicotine Tobacco Res 3:203-223
42. Levin ED (2002) Nicotinic receptor subtypes and cognitive function. J Neurobiol 53:633-640
43. Levin ED, McClernon FJ, Rezvani AH (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification and anatomic localization. Psychopharmacology 184:523-539
44. Levin ED, Rezvani AH (2000) Development of nicotinic drug therapy for cognitive disorders. Eur Pharmacol 393:141-146
45. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138:217-230
46. Levy A, Kong RM, Stillman MJ, Shukitt-Hale B, Kadar T, Rauch T, Lieberman HR (1991) Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats. Pharmacol Biochem Behav 39:781-786
47. Mansvelder HD, McGehee DS (2000) Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27:349-357
48. Mansvelder HD, McGehee DS (2002) Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53:606-617
49. Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo- Jimenez MM et al (2003) Effects of nicotine in the dopaminergic system of mice lacking the alpha 4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17:1327-1337
50. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP et al (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436:103-107
51. Mason PR, Walter MF, Trumbore MW, Olmstead EG, Mason PE (1999) Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J Mol Cell Cardiol 31:275-281
52. Maurice T, Bayle J, Privat A (1995) Learning impairment following acute administration of the calcium channel antagonist nimodipine in mice. Behav Pharmacol 6:167-175
53. Maxwell CJ, Hogan DB, Ebly EM (1999) Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ 161:501-506
54. Miller RJ (1987) Multiple calcium channels and neuronal function. Science 235:46-51
55. Moaddel R, Jozwiak K, Wainer IW (2007) Allosteric modifiers of neuronal nicotinic acetylcholine receptors: new methods, new opportunities. Med Res Rev 27:723-753
56. Morgan SL, Teyler TJ (1999) VDCCs and NMDARs underlie two forms of LTP in CA1 hippocampus in vivo. J Neurophysiol 82:736-740
57. Newhouse PA, Potter A, Levin ED (1997) Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11:206-228
58. Nicoll RA, Malenka RC (1995) Contrasting properties of two forms of long term potentiation in the hippocampus. Nature 377:115-117
59. Nikolaev E, Kaczmarek L (1994) Disruption of two-way active avoidance behavior by nimodipine. Pharmacol Biochem Behav 47:757-759
60. Paris D, Bachmeier C, Patel N, Quadros A, Volmar C-H, Laporte V et al (2011) Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier. Mol Med 17:149-162
61. Paterson D, Nordberg A (2000) Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-111
62. Picciotto MR, Caldarone BJ, King SL, Zachariou V (2000) Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 22:451-465
63. Picciotto MR, Zoli M (2002) Nicotinic receptors in aging and dementia. J Neurobiol 53:641-655
64. Puma C, Deschaux O, Molimard R, Bizot JC (1999) Nicotine improves memory in an object recognition task in rats. Eur Neuropsychopharmacol 9:323-327
65. 2+ channel blocker amlodipine facilitates learning and memory in mice. Eur J Pharmacol 399:57-63
66. Quartermain D, Garcia DeSoria V, Kwan A (2001) Calcium channel antagonists enhance retention of passive avoidance and maze learning in mice. Neurobiol Learn Memory 75:77-90
67. Quartermain D, Hawxhurst A, Ermita B, Puente J (1993) Effect of the calcium channel blocker amlodipine on memory in mice. Behav Neural Biol 60:211-219
68. Quevedo J, Vianna M, Daroit D, Born AG, Kuyven CR, Roesler R, Quillfeldt JA (1998) L type voltage-dependent calcium channel blocker nifedipine enhances memory retention when infused into the hippocampus. Neurobiol Learn Mem 69:320-325
69. Rezvani AH, Levin ED (1998) Cognitive effects of nicotine. Biol Psychiat 49:258-267
70. Sabbagh MN, Lukas RJ, Sparks DL, Reid RT (2002) The nicotinic acetylcholine receptor, smoking, and Alzheimer's disease. J Alzheimers Dis 4:317-325
71. Sharma AC, Kulkarni SK (1992) Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog Neuropsychopharmacol Biol Psychiatry 16:117-125
72. Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321-327
73. Stolerman IP, Shoaib M (1991) The neurobiology of tobacco addiction. Trends Pharmacol Sci 12:467-473
74. 2+ channels. Eur J Pharmacol 375:311-325
75. Vetulani J, Battaglia M, Sansone M (1997) Nimodipine on shuttle box avoidance learning in mice: no impairment but slight improvement. Pharmacol Biochem Behav 56:577-581
76. Wang H, Sun X (2005) Desensitized nicotinic receptors in brain. Brain Res Rev 48:420-437
77. Wheeler DG, Barrett CF, Tsien RW (2006) L-type calcium channel ligands block nicotine-induced signaling to CREB by inhibiting nicotinic receptors. Neuropharmacology 51:27-36
78. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98
79. Woodside BL, Borroni AM, Hammonds MD, Teyler TJ (2004) NMDA receptors and voltage-dependent calcium channels mediate different aspects of acquisition and retention of a spatial memory task. Neurobiol Learn Memory 81:105-114
80. Zaniewska M, Przegalinski E, Filip M (2009) Nicotine dependence - human and animal studies, current pharmacotherapies and future perspectives. Pharmacol Rep 61:957-965
81. Zupan G, Vitezic D, Mrsic J, Matesic D, Simonic A (1996) Effects of nimodipine, felodipine and amlodipine on electroconvulsive shock-induced amnesia in the rat. Eur J Pharmacol 310:103-106